Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals - Peer2Peer

Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals

Sep 20, 2024

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.(Image credit: Fabrice Coffrini)

https://www.npr.org/2024/09/20/nx-s1-5121020/philip-morris-sells-asthma-inhaler-company-citing-unwarranted-opposition-to-its-goals

Respond, make new discussions, see other discussions and customize your news...
Log in.

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Terms of Service